In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price target of $101.00. Whit Mayo has given his Hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback